Suprema has unveiled BioStar X, which it considers its most advanced unified security platform to date. Designed to integrate biometric access control and video surveillance into a single, scalable ...
Khronos OpenVX is an open, royalty-free standard API for cross platform acceleration of computer vision applications. OpenVX enables performance and power-optimized computer vision functionality, ...
LOS ANGELES, CA / ACCESS Newswire / August 8, 2025 / Biostar Stem Cell Technology Research Institute, led by Director Jeong Chan Ra and jointly operated by R BIO and Nature Cell, announced that its ...
NORTHAMPTON, MA / ACCESS Newswire / June 4, 2025 / At BioStar Renewables, we believe that accelerating the energy transition requires more than cutting-edge technology-it takes people with purpose, ...
BIOSTAR has highlighted a lineup of industrial edge computing, edge AI platforms, and AI PC solutions at COMPUTEX 2025. The brand’s COMPUTEX 2025 showcase centers on its edge AI platforms and new ...
SEOUL, KOREA May 7, 2025 – Suprema, a global leader in AI-powered access control and security solutions, officially announced the launch of BioStar Air, the first and only cloud-based access control ...
Suprema has introduced the latest entry in its well-known BioStar line of biometric scanners for access control and human resource management to allow organizations to deploy it with “zero-on-premise” ...
NORTHAMPTON, MA / ACCESS Newswire / April 4, 2025 / BioStar Renewables is proud to have partnered with Seaboard Energy, LLC to develop and construct a behind-the-meter solar array that is producing ...
BIOSTAR, a leading manufacturer of IPC solutions, motherboards, graphics cards, and PC peripherals, is set to showcase its latest industrial computing and edge AI computing solutions at the upcoming ...
Antonia Haynes is a Game Rant writer who resides in a small seaside town in England where she has lived her whole life. Beginning her video game writing career in 2014, and having an avid love of ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果